• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
IBD: Patients with IBD find symptom relief in the Cannabis field.炎症性肠病：炎症性肠病患者在大麻领域中获得症状缓解。
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):142-3. doi: 10.1038/nrgastro.2013.245. Epub 2013 Dec 24.
2
Cannabis use amongst patients with inflammatory bowel disease.炎症性肠病患者的大麻使用情况。
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.
3
Marijuana use patterns among patients with inflammatory bowel disease.炎症性肠病患者的大麻使用模式。
Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.
4
Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study.新西兰炎症性肠病患者对大麻的态度和使用情况：一项探索性研究。
N Z Med J. 2021 Feb 19;134(1530):38-47.
5
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.大麻的使用可以缓解炎症性肠病患者的症状，但与克罗恩病患者的更差的疾病预后相关。
Inflamm Bowel Dis. 2014 Mar;20(3):472-80. doi: 10.1097/01.MIB.0000440982.79036.d6.
6
Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.医用大麻合法化对炎症性肠病患者的使用模式影响极小。
Inflamm Bowel Dis. 2018 Oct 12;24(11):2309-2314. doi: 10.1093/ibd/izy141.
7
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.大麻治疗对炎症性肠病患者生活质量、体重和临床疾病活动的影响：一项前瞻性初步研究。
Digestion. 2012;85(1):1-8. doi: 10.1159/000332079. Epub 2011 Nov 17.
8
Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?大麻、大麻素和内源性大麻素系统——对炎症性肠病是否有治疗潜力？
J Crohns Colitis. 2019 Mar 30;13(4):525-535. doi: 10.1093/ecco-jcc/jjy185.
9
Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.大麻，儿科炎症性肠病的潜在治疗选择？仍有很长的路要走。
Expert Rev Clin Pharmacol. 2019 Apr;12(4):355-361. doi: 10.1080/17512433.2019.1582330. Epub 2019 Feb 26.
10
An overview of cannabis based treatment in Crohn's disease.大麻素治疗克罗恩病概述。
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):253-257. doi: 10.1080/17474124.2020.1740590. Epub 2020 Mar 12.

引用本文的文献

1
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.内源性大麻素系统作为炎症性肠病有前途的治疗靶点——系统评价。
Front Immunol. 2021 Dec 22;12:790803. doi: 10.3389/fimmu.2021.790803. eCollection 2021.
2
Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.活动期大麻使用者炎症性肠病的症状和肠外表现。
Cannabis Cannabinoid Res. 2022 Aug;7(4):445-450. doi: 10.1089/can.2020.0155. Epub 2021 Mar 24.
3
Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.内源性大麻素系统调节在眼部疼痛和炎症中的潜力：填补当前药理学选择的空白。
Neuronal Signal. 2018 Nov 2;2(4):NS20170144. doi: 10.1042/NS20170144. eCollection 2018 Dec.
4
Modulation of the Endocannabinoid System Following Central Nervous System Injury.中枢神经系统损伤后内源性大麻素系统的调制。
Int J Mol Sci. 2019 Jan 17;20(2):388. doi: 10.3390/ijms20020388.
5
QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling.清肠饮通过调节 Notch 和 NF-κB 信号通路调节葡聚糖硫酸钠诱导的结肠炎的肠通透性。
Cell Prolif. 2019 Mar;52(2):e12547. doi: 10.1111/cpr.12547. Epub 2019 Jan 18.
6
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.内源性大麻素系统参数作为脓毒症和脓毒性休克中的新型生物标志物
Metabolites. 2017 Nov 1;7(4):55. doi: 10.3390/metabo7040055.
7
Therapeutic Use of Cannabis in Inflammatory Bowel Disease.大麻在炎症性肠病中的治疗应用。
Gastroenterol Hepatol (N Y). 2016 Nov;12(11):668-679.
8
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.大麻与儿童炎症性肠病：一英里高空的变革之花
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):265-271. doi: 10.1097/MPG.0000000000001393.

本文引用的文献

1
Marijuana use patterns among patients with inflammatory bowel disease.炎症性肠病患者的大麻使用模式。
Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.
2
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.大麻可诱导克罗恩病患者产生临床应答：一项前瞻性安慰剂对照研究。
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
3
A potential role for GPR55 in gastrointestinal functions.GPR55 在胃肠道功能中的潜在作用。
Curr Opin Pharmacol. 2012 Dec;12(6):653-8. doi: 10.1016/j.coph.2012.09.009. Epub 2012 Oct 10.
4
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.炎症性肠病中的内源性大麻素系统：从病理生理学到治疗机会。
Trends Mol Med. 2012 Oct;18(10):615-25. doi: 10.1016/j.molmed.2012.07.009. Epub 2012 Aug 21.
5
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.一项关于吸烟与女性炎症性肠病风险的前瞻性研究。
Am J Gastroenterol. 2012 Sep;107(9):1399-406. doi: 10.1038/ajg.2012.196. Epub 2012 Jul 10.
6
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.大麻治疗对炎症性肠病患者生活质量、体重和临床疾病活动的影响：一项前瞻性初步研究。
Digestion. 2012;85(1):1-8. doi: 10.1159/000332079. Epub 2011 Nov 17.
7
Cannabis use amongst patients with inflammatory bowel disease.炎症性肠病患者的大麻使用情况。
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.
8
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.炎症性肠病患者肠道中的内源性大麻素系统。
Mucosal Immunol. 2011 Sep;4(5):574-83. doi: 10.1038/mi.2011.18. Epub 2011 Apr 6.
9
Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.溃疡性结肠炎诱导人结肠组织中环烷烃系统表达的变化。
PLoS One. 2009 Sep 4;4(9):e6893. doi: 10.1371/journal.pone.0006893.
10
Pharmacological actions of cannabinoids.大麻素的药理作用。
Handb Exp Pharmacol. 2005(168):1-51. doi: 10.1007/3-540-26573-2_1.

炎症性肠病：炎症性肠病患者在大麻领域中获得症状缓解。

IBD: Patients with IBD find symptom relief in the Cannabis field.

作者信息

Schicho Rudolf, Storr Martin

机构信息

Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Universitätsplatz 4, 8010 Graz, Austria.

Department of Medicine II, Klinikum Grosshadern, Ludwig-Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany.

出版信息

Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):142-3. doi: 10.1038/nrgastro.2013.245. Epub 2013 Dec 24.

DOI:10.1038/nrgastro.2013.245
PMID:24366227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3947743/
Abstract

Cannabis (or marijuana) has been used in traditional medicine to treat intestinal inflammation and is used as a self-medication by patients with inflammatory bowel disease (IBD). A survey by Ravikoff Allegretti et al. at a specialized IBD clinic shows that, in the US, marijuana is used by a significant number of patients with IBD to alleviate their symptoms.

摘要

大麻（或 marijuana）已被用于传统医学中治疗肠道炎症，并且被炎症性肠病（IBD）患者用作自我治疗药物。拉维科夫·阿莱格雷蒂等人在一家专门的IBD诊所进行的一项调查显示，在美国，相当多的IBD患者使用大麻来缓解症状。